Multiparametric magnetic resonance imaging for hepatocellular carcinoma, part 1 : Morphology and dynamic perfusion imaging in primary diagnostics and treatment monitoring
© 2024. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature..
Radiology plays a key role in the diagnosis and monitoring of hepatocellular carcinoma (HCC). Ultrasound, computed tomography (CT) and magnetic resonance imaging (MRI) are used to identify HCC lesions. Multiparametric MRI provides detailed insights into the tumor biology through the analysis of morphology, perfusion and diffusion. In this way preoperative decisions can be optimized. The guidelines recommend using contrast-enhanced MRI or ultrasound for the diagnosis of HCC. The preferred method is MRI due to its superiority in the detection of small lesions The treatment response is evaluated using modified response evaluation criteria for solid tumors (RECIST) and the European Association for the Study of the Liver (EASL) criteria. The use of multiparametric MRI in conjunction with the liver imaging reporting and data system (LI-RADS) plays overall a central role in the precise diagnosis and monitoring of the treatment of HCC.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:64 |
|---|---|
| Enthalten in: |
Radiologie (Heidelberg, Germany) - 64(2024), 4 vom: 27. März, Seite 321-332 |
| Sprache: |
Deutsch |
|---|
| Weiterer Titel: |
Multiparametrische MRT-Bildgebung beim hepatozellulären Karzinom, Teil 1 : Morphologie und dynamische Perfusionsbildgebung in Primärdiagnostik und Therapieverlaufskontrolle |
|---|
| Beteiligte Personen: |
Jahn, Mona [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
English Abstract |
|---|
| Anmerkungen: |
Date Completed 28.03.2024 Date Revised 28.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00117-024-01285-1 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369920104 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369920104 | ||
| 003 | DE-627 | ||
| 005 | 20240329000857.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240320s2024 xx |||||o 00| ||ger c | ||
| 024 | 7 | |a 10.1007/s00117-024-01285-1 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1353.xml |
| 035 | |a (DE-627)NLM369920104 | ||
| 035 | |a (NLM)38502373 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a ger | ||
| 100 | 1 | |a Jahn, Mona |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Multiparametric magnetic resonance imaging for hepatocellular carcinoma, part 1 |b Morphology and dynamic perfusion imaging in primary diagnostics and treatment monitoring |
| 246 | 3 | 3 | |a Multiparametrische MRT-Bildgebung beim hepatozellulären Karzinom, Teil 1 : Morphologie und dynamische Perfusionsbildgebung in Primärdiagnostik und Therapieverlaufskontrolle |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.03.2024 | ||
| 500 | |a Date Revised 28.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2024. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature. | ||
| 520 | |a Radiology plays a key role in the diagnosis and monitoring of hepatocellular carcinoma (HCC). Ultrasound, computed tomography (CT) and magnetic resonance imaging (MRI) are used to identify HCC lesions. Multiparametric MRI provides detailed insights into the tumor biology through the analysis of morphology, perfusion and diffusion. In this way preoperative decisions can be optimized. The guidelines recommend using contrast-enhanced MRI or ultrasound for the diagnosis of HCC. The preferred method is MRI due to its superiority in the detection of small lesions The treatment response is evaluated using modified response evaluation criteria for solid tumors (RECIST) and the European Association for the Study of the Liver (EASL) criteria. The use of multiparametric MRI in conjunction with the liver imaging reporting and data system (LI-RADS) plays overall a central role in the precise diagnosis and monitoring of the treatment of HCC | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Hepatocellular carcinoma | |
| 650 | 4 | |a Liver-specific contrast agents | |
| 650 | 4 | |a Multiparametric magnetic resonance imaging | |
| 650 | 4 | |a Primary diagnosis | |
| 650 | 4 | |a Treatment response | |
| 700 | 1 | |a Layer, Günter |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Radiologie (Heidelberg, Germany) |d 2022 |g 64(2024), 4 vom: 27. März, Seite 321-332 |w (DE-627)NLM338822127 |x 2731-7056 |7 nnns |
| 773 | 1 | 8 | |g volume:64 |g year:2024 |g number:4 |g day:27 |g month:03 |g pages:321-332 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00117-024-01285-1 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 64 |j 2024 |e 4 |b 27 |c 03 |h 321-332 | ||